Matthew Larson, Chief Risk Officer of Slide Insurance Holdings, Inc. (NASDAQ: SLDE), disposed of his entire direct holding of common stock through two sales in April 2026, according to a Form 4 filing with the Securities and Exchange Commission.
The filing shows a total of 20,000 shares were sold for approximately $384,387. The trades occurred on two dates and followed the exercise of stock options for the same number of shares at an exercise price of $0.79 per share.
On April 16, 2026, Mr. Larson sold 8,750 shares of Slide Insurance common stock at $19.00 per share, producing proceeds of $166,250. Those shares had been acquired immediately beforehand through the exercise of options at $0.79 per share, representing an outlay of $6,912.50 for the exercised options.
Four days later, on April 20, 2026, Mr. Larson sold another 11,250 shares. The filing records a weighted average sale price of $19.39 per share for that block, totaling $218,137. Footnotes to the filing indicate the individual sale prices in that tranche ranged from $18.97 to $19.91 per share. These 11,250 shares had likewise been obtained via option exercises at $0.79 per share, for a reported exercise cost of $8,887.50.
Taken together, Mr. Larson exercised options to acquire 20,000 shares for a combined exercise cost of $15,800 and subsequently sold those shares in the two April transactions. The Form 4 notes that all of these exercises and sales were carried out pursuant to a 10b5-1 trading plan that Mr. Larson adopted on December 4, 2025. The filing also states the stock options exercised were fully vested and exercisable.
Following the completion of these transactions, the filing indicates Mr. Larson holds 0 shares of Slide Insurance Holdings, Inc. common stock directly.
Context in the market: Slide Insurance shares have exhibited notable momentum over recent months. InvestingPro data cited in the filing materials shows a six-month price return of 27%. At the time of those trades the per-share sale prices were modestly above the companys then-current quote; the stock currently trades at $18.98, slightly below the transaction prices recorded in the filing. InvestingPro's Fair Value analysis referenced alongside the trading activity characterizes the stock as appearing undervalued at present.
Additional financial metrics included in the background materials portray Slide Insurance as financially robust. The company carries an "EXCELLENT" financial health score of 3.94 in the InvestingPro framework and reported earnings per share of $3.36 over the last twelve months as of fourth-quarter 2025.
Operational and shareholder-return developments were also disclosed in recent company updates. Slide Insurance reported fourth-quarter 2025 earnings per share of $1.23, markedly above the consensus projection of $0.71, representing a 73.24% surprise versus estimates. Revenue for the quarter rose to $347 million, up from $238.5 million the prior year. The company completed a $120 million stock buyback program and authorized an additional $125 million buyback initiative.
Analyst commentary since the earnings release has generally leaned positive. Barclays reiterated an Overweight rating with a $29 price target. Texas Capital Securities initiated coverage with a Buy rating and a $25 price target. Keefe, Bruyette & Woods increased its price target to $23, citing the strong fourth-quarter results and continued strength in particular business areas.
The Form 4 filing and the accompanying corporate disclosures provide a transparent record of the option exercises and subsequent sales executed by Mr. Larson under a pre-established trading plan. They also come amid a period of improved operating results and renewed analyst interest in Slide Insurance.